Biased agonism: the quest for the analgesic holy grail
Abstract. Opioids alleviate pain, but adverse effects severely limit their usefulness. To solve this problem, biased ligands favoring 1 signaling pathway downstream of the μ-opioid receptor over another are being developed. In the target article, the authors synthesize compounds that preferentially...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2018-06-01
|
Series: | PAIN Reports |
Online Access: | http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000000650 |